Use of Clarithromycin and Adverse Cardiovascular Events among Older Patients Receiving Donepezil View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2012-03

AUTHORS

Janine R. Hutson, Hadas D. Fischer, Xuesong Wang, Andrea Gruneir, Nick Daneman, Sudeep S. Gill, Paula A. Rochon, Geoffrey M. Anderson

ABSTRACT

BACKGROUND: Donepezil is a commonly used drug in older people that due to its procholinergic effects can provoke bradycardia and neurocardiogenic syncope. Donepezil is metabolized by the cytochrome P450 isozyme 3A4 (CYP3A4). Clarithromycin is a potent inhibitor of CYP3A4, and patients taking both of these drugs may be at increased risk of cardiac adverse events. OBJECTIVE: The aim of this study was to evaluate the association between recent use of clarithromycin and adverse cardiovascular events in elderly patients receiving donepezil. METHODS: A population-based, nested case-control study using provincial healthcare databases was conducted. The base cohort was made up of persons 66 years of age or older who were prescribed donepezil and also were prescribed clarithromycin, erythromycin, azithromycin, cefuroxime, moxifloxacin or levofloxacin. Cases were those members of the base cohort hospitalized for bradycardia, syncope or complete atrioventricular block. For each case patient, five controls were matched according to age, sex and residence (community or long-term care). RESULTS: Between July 2002 and March 2010, 17,712 patients continuously receiving donepezil were prescribed one of the antibacterials. In 1400 person-years of follow-up, 59 cases were identified. As compared with azithromycin, there was no statistically significant association between use of clarithromycin in donepezil users and subsequent adverse cardiovascular events (odds ratio 0.67; 95% CI 0.28, 1.63). There was no significant risk associated with exposure to either cefuroxime or respiratory quinolones. CONCLUSIONS: The use of clarithromycin in elderly donepezil users did not significantly increase the risk of adverse cardiovascular outcomes. However, our study cannot rule out a possible small increase in risk. Although antibacterials can be beneficial, care should be taken in selecting antibacterials for use in older people receiving donepezil. More... »

PAGES

205-211

References to SciGraph publications

Identifiers

URI

http://scigraph.springernature.com/pub.10.2165/11599090-000000000-00000

DOI

http://dx.doi.org/10.2165/11599090-000000000-00000

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1009392785

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/22372724


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1117", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Public Health and Health Services", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Aged, 80 and over", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Anti-Bacterial Agents", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Atrioventricular Block", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Bradycardia", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Cardiovascular Diseases", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Case-Control Studies", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Cholinesterase Inhibitors", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Clarithromycin", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Cohort Studies", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Cytochrome P-450 CYP3A Inhibitors", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Drug Interactions", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Drug Prescriptions", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Enzyme Inhibitors", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Indans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Macrolides", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Ontario", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Piperidines", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Syncope", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "University of Toronto", 
          "id": "https://www.grid.ac/institutes/grid.17063.33", 
          "name": [
            "Faculty of Medicine, University of Toronto, Toronto, ON, Canada"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Hutson", 
        "givenName": "Janine R.", 
        "id": "sg:person.0653763073.75", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0653763073.75"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "Sunnybrook Health Sciences Centre, Institute for Clinical Evaluative Sciences, Toronto, ON, Canada"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Fischer", 
        "givenName": "Hadas D.", 
        "id": "sg:person.01144717762.18", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01144717762.18"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "Sunnybrook Health Sciences Centre, Institute for Clinical Evaluative Sciences, Toronto, ON, Canada"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Wang", 
        "givenName": "Xuesong", 
        "id": "sg:person.01056752152.84", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01056752152.84"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "University of Toronto", 
          "id": "https://www.grid.ac/institutes/grid.17063.33", 
          "name": [
            "Sunnybrook Health Sciences Centre, Institute for Clinical Evaluative Sciences, Toronto, ON, Canada", 
            "Women\u2019s College Research Institute, Women\u2019s College Hospital, Toronto, ON, Canada", 
            "Institute of Health Policy, Management, and Evaluation, University of Toronto, Toronto, ON, Canada"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Gruneir", 
        "givenName": "Andrea", 
        "id": "sg:person.01234641247.26", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01234641247.26"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "Sunnybrook Health Sciences Centre, Institute for Clinical Evaluative Sciences, Toronto, ON, Canada"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Daneman", 
        "givenName": "Nick", 
        "id": "sg:person.01364536725.09", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01364536725.09"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Queen's University", 
          "id": "https://www.grid.ac/institutes/grid.410356.5", 
          "name": [
            "Sunnybrook Health Sciences Centre, Institute for Clinical Evaluative Sciences, Toronto, ON, Canada", 
            "Department of Medicine, Queen\u2019s University, Kingston, ON, Canada"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Gill", 
        "givenName": "Sudeep S.", 
        "id": "sg:person.01261146362.20", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01261146362.20"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "University of Toronto", 
          "id": "https://www.grid.ac/institutes/grid.17063.33", 
          "name": [
            "Faculty of Medicine, University of Toronto, Toronto, ON, Canada", 
            "Sunnybrook Health Sciences Centre, Institute for Clinical Evaluative Sciences, Toronto, ON, Canada", 
            "Women\u2019s College Research Institute, Women\u2019s College Hospital, Toronto, ON, Canada", 
            "Institute of Health Policy, Management, and Evaluation, University of Toronto, Toronto, ON, Canada"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Rochon", 
        "givenName": "Paula A.", 
        "id": "sg:person.01005772611.81", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01005772611.81"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "University of Toronto", 
          "id": "https://www.grid.ac/institutes/grid.17063.33", 
          "name": [
            "Sunnybrook Health Sciences Centre, Institute for Clinical Evaluative Sciences, Toronto, ON, Canada", 
            "Women\u2019s College Research Institute, Women\u2019s College Hospital, Toronto, ON, Canada", 
            "Institute of Health Policy, Management, and Evaluation, University of Toronto, Toronto, ON, Canada"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Anderson", 
        "givenName": "Geoffrey M.", 
        "id": "sg:person.013547764572.30", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.013547764572.30"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "https://doi.org/10.1159/000068781", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1002677138"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1001/archinternmed.2010.37", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1008758374"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.jjcc.2009.03.011", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1009008299"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1086/313959", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1015775451"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/pds.1746", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1018332592"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/pds.1746", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1018332592"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1093/ageing/afq158", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1024045720"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1056/nejmoa055191", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1027423537"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00228-006-0168-1", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1030133192", 
          "https://doi.org/10.1007/s00228-006-0168-1"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00228-006-0168-1", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1030133192", 
          "https://doi.org/10.1007/s00228-006-0168-1"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1111/j.1532-5415.2009.02488.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1032550522"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1111/j.1532-5415.2009.02488.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1032550522"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1345/aph.1l432", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1033480476"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1345/aph.1l432", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1033480476"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1046/j.1525-1497.2001.016006376.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1034909896", 
          "https://doi.org/10.1046/j.1525-1497.2001.016006376.x"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1503/cmaj.100702", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1037966301"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1503/cmaj.100702", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1037966301"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00228-005-0946-1", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1038725195", 
          "https://doi.org/10.1007/s00228-005-0946-1"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00228-005-0946-1", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1038725195", 
          "https://doi.org/10.1007/s00228-005-0946-1"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00228-005-0946-1", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1038725195", 
          "https://doi.org/10.1007/s00228-005-0946-1"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1001/archinternmed.2009.43", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1039314358"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1371/journal.pmed.1000157", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1042241562"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/clpt.2009.127", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1049257231", 
          "https://doi.org/10.1038/clpt.2009.127"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1046/j.1365-2125.1998.0460s1025.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1056732607"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1046/j.1365-2125.1998.0460s1030.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1056732608"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2012-03", 
    "datePublishedReg": "2012-03-01", 
    "description": "BACKGROUND: Donepezil is a commonly used drug in older people that due to its procholinergic effects can provoke bradycardia and neurocardiogenic syncope. Donepezil is metabolized by the cytochrome P450 isozyme 3A4 (CYP3A4). Clarithromycin is a potent inhibitor of CYP3A4, and patients taking both of these drugs may be at increased risk of cardiac adverse events.\nOBJECTIVE: The aim of this study was to evaluate the association between recent use of clarithromycin and adverse cardiovascular events in elderly patients receiving donepezil.\nMETHODS: A population-based, nested case-control study using provincial healthcare databases was conducted. The base cohort was made up of persons 66 years of age or older who were prescribed donepezil and also were prescribed clarithromycin, erythromycin, azithromycin, cefuroxime, moxifloxacin or levofloxacin. Cases were those members of the base cohort hospitalized for bradycardia, syncope or complete atrioventricular block. For each case patient, five controls were matched according to age, sex and residence (community or long-term care).\nRESULTS: Between July 2002 and March 2010, 17,712 patients continuously receiving donepezil were prescribed one of the antibacterials. In 1400 person-years of follow-up, 59 cases were identified. As compared with azithromycin, there was no statistically significant association between use of clarithromycin in donepezil users and subsequent adverse cardiovascular events (odds ratio 0.67; 95% CI 0.28, 1.63). There was no significant risk associated with exposure to either cefuroxime or respiratory quinolones.\nCONCLUSIONS: The use of clarithromycin in elderly donepezil users did not significantly increase the risk of adverse cardiovascular outcomes. However, our study cannot rule out a possible small increase in risk. Although antibacterials can be beneficial, care should be taken in selecting antibacterials for use in older people receiving donepezil.", 
    "genre": "research_article", 
    "id": "sg:pub.10.2165/11599090-000000000-00000", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1100990", 
        "issn": [
          "1170-229X", 
          "1179-1969"
        ], 
        "name": "Drugs & Aging", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "3", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "29"
      }
    ], 
    "name": "Use of Clarithromycin and Adverse Cardiovascular Events among Older Patients Receiving Donepezil", 
    "pagination": "205-211", 
    "productId": [
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "2cbe6e73eecccaaad6868c3c9cde97f0b22fa28068700b7dc2b67328a4aa8fc8"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "22372724"
        ]
      }, 
      {
        "name": "nlm_unique_id", 
        "type": "PropertyValue", 
        "value": [
          "9102074"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.2165/11599090-000000000-00000"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1009392785"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.2165/11599090-000000000-00000", 
      "https://app.dimensions.ai/details/publication/pub.1009392785"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-10T21:41", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000001_0000000264/records_8687_00000536.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "http://link.springer.com/10.2165%2F11599090-000000000-00000"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.2165/11599090-000000000-00000'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.2165/11599090-000000000-00000'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.2165/11599090-000000000-00000'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.2165/11599090-000000000-00000'


 

This table displays all metadata directly associated to this object as RDF triples.

277 TRIPLES      21 PREDICATES      69 URIs      43 LITERALS      31 BLANK NODES

Subject Predicate Object
1 sg:pub.10.2165/11599090-000000000-00000 schema:about N0adb597897f5418184ec82d7b3fa12c6
2 N103203b964d744e180da6778e8c9cbf7
3 N2ba3c7fd78a642098c0858d716e0aa2e
4 N341bf71b5f2e4323918122789d7c893f
5 N5538259e050c4cfbbebbd7a225e32a2a
6 N5ab97b48dcb04404ad40b5f44e132164
7 N64a0e09d5b2048d78f8b908c1080bcf4
8 N6885a26ac3e74e84aa8ca70242107ac5
9 N74fda738023b4ad6b98df66d1ef21ba0
10 N84b09424fe954d7ea6a615e64c60e8f2
11 N95d30dfc24a549e28434852d1e0ebf98
12 N996014262d5d43a9b80af89350a0a140
13 Na954049789894d9c97331e04832f8cff
14 Nacf52cb65ab64ca3a0e2ecb2ae821c78
15 Nae547a0332a84e56ab8e443c195f9e02
16 Naf3168c321db4540b138ff662c1ac2c1
17 Nc0237d71d28f49c3b5ed09ed12172b50
18 Nc7f32303cbc640e9a366c72dd1da1d3d
19 Ncbf778a7d73d47b5b49f539b37277ad6
20 Nd8fa63087089405d9bb3593270f5d543
21 Ne619040c0ff34d3582c2a5513086f518
22 Nea6bcb5dca34425787782b18dd29a0ec
23 anzsrc-for:11
24 anzsrc-for:1117
25 schema:author N2285b7619b9542b49d2b8b74f433209e
26 schema:citation sg:pub.10.1007/s00228-005-0946-1
27 sg:pub.10.1007/s00228-006-0168-1
28 sg:pub.10.1038/clpt.2009.127
29 sg:pub.10.1046/j.1525-1497.2001.016006376.x
30 https://doi.org/10.1001/archinternmed.2009.43
31 https://doi.org/10.1001/archinternmed.2010.37
32 https://doi.org/10.1002/pds.1746
33 https://doi.org/10.1016/j.jjcc.2009.03.011
34 https://doi.org/10.1046/j.1365-2125.1998.0460s1025.x
35 https://doi.org/10.1046/j.1365-2125.1998.0460s1030.x
36 https://doi.org/10.1056/nejmoa055191
37 https://doi.org/10.1086/313959
38 https://doi.org/10.1093/ageing/afq158
39 https://doi.org/10.1111/j.1532-5415.2009.02488.x
40 https://doi.org/10.1159/000068781
41 https://doi.org/10.1345/aph.1l432
42 https://doi.org/10.1371/journal.pmed.1000157
43 https://doi.org/10.1503/cmaj.100702
44 schema:datePublished 2012-03
45 schema:datePublishedReg 2012-03-01
46 schema:description BACKGROUND: Donepezil is a commonly used drug in older people that due to its procholinergic effects can provoke bradycardia and neurocardiogenic syncope. Donepezil is metabolized by the cytochrome P450 isozyme 3A4 (CYP3A4). Clarithromycin is a potent inhibitor of CYP3A4, and patients taking both of these drugs may be at increased risk of cardiac adverse events. OBJECTIVE: The aim of this study was to evaluate the association between recent use of clarithromycin and adverse cardiovascular events in elderly patients receiving donepezil. METHODS: A population-based, nested case-control study using provincial healthcare databases was conducted. The base cohort was made up of persons 66 years of age or older who were prescribed donepezil and also were prescribed clarithromycin, erythromycin, azithromycin, cefuroxime, moxifloxacin or levofloxacin. Cases were those members of the base cohort hospitalized for bradycardia, syncope or complete atrioventricular block. For each case patient, five controls were matched according to age, sex and residence (community or long-term care). RESULTS: Between July 2002 and March 2010, 17,712 patients continuously receiving donepezil were prescribed one of the antibacterials. In 1400 person-years of follow-up, 59 cases were identified. As compared with azithromycin, there was no statistically significant association between use of clarithromycin in donepezil users and subsequent adverse cardiovascular events (odds ratio 0.67; 95% CI 0.28, 1.63). There was no significant risk associated with exposure to either cefuroxime or respiratory quinolones. CONCLUSIONS: The use of clarithromycin in elderly donepezil users did not significantly increase the risk of adverse cardiovascular outcomes. However, our study cannot rule out a possible small increase in risk. Although antibacterials can be beneficial, care should be taken in selecting antibacterials for use in older people receiving donepezil.
47 schema:genre research_article
48 schema:inLanguage en
49 schema:isAccessibleForFree false
50 schema:isPartOf N5917559cd3594f649b7cd22273473df9
51 N793c0381988a49b7a7bdfa4fd4253c6c
52 sg:journal.1100990
53 schema:name Use of Clarithromycin and Adverse Cardiovascular Events among Older Patients Receiving Donepezil
54 schema:pagination 205-211
55 schema:productId N64825870e1d14609a8cb65bb88612a2e
56 N8bb632a180994ad1af86bd4a6814925e
57 Naeb1c1f17fa04e668ff96d4274488e67
58 Ndd98dbf384db4b6c99da10c2f3e415c0
59 Nfa13abceb07e435f973b8c927cb09aa7
60 schema:sameAs https://app.dimensions.ai/details/publication/pub.1009392785
61 https://doi.org/10.2165/11599090-000000000-00000
62 schema:sdDatePublished 2019-04-10T21:41
63 schema:sdLicense https://scigraph.springernature.com/explorer/license/
64 schema:sdPublisher N570683b0eb084bfeb618fd7b4b5273b4
65 schema:url http://link.springer.com/10.2165%2F11599090-000000000-00000
66 sgo:license sg:explorer/license/
67 sgo:sdDataset articles
68 rdf:type schema:ScholarlyArticle
69 N0adb597897f5418184ec82d7b3fa12c6 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
70 schema:name Cholinesterase Inhibitors
71 rdf:type schema:DefinedTerm
72 N103203b964d744e180da6778e8c9cbf7 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
73 schema:name Enzyme Inhibitors
74 rdf:type schema:DefinedTerm
75 N1a256317034e4a6a89bb3b6d77c02f11 rdf:first sg:person.01005772611.81
76 rdf:rest N33ec97354bb244dcb5195518fe41bfce
77 N2285b7619b9542b49d2b8b74f433209e rdf:first sg:person.0653763073.75
78 rdf:rest Nb2212656afc54aa6b6416e399d6db0d0
79 N2ba3c7fd78a642098c0858d716e0aa2e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
80 schema:name Ontario
81 rdf:type schema:DefinedTerm
82 N33ec97354bb244dcb5195518fe41bfce rdf:first sg:person.013547764572.30
83 rdf:rest rdf:nil
84 N341bf71b5f2e4323918122789d7c893f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
85 schema:name Syncope
86 rdf:type schema:DefinedTerm
87 N40eaa66743124fe88e4d6b167b17a415 schema:name Sunnybrook Health Sciences Centre, Institute for Clinical Evaluative Sciences, Toronto, ON, Canada
88 rdf:type schema:Organization
89 N5538259e050c4cfbbebbd7a225e32a2a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
90 schema:name Drug Prescriptions
91 rdf:type schema:DefinedTerm
92 N570683b0eb084bfeb618fd7b4b5273b4 schema:name Springer Nature - SN SciGraph project
93 rdf:type schema:Organization
94 N5917559cd3594f649b7cd22273473df9 schema:issueNumber 3
95 rdf:type schema:PublicationIssue
96 N5ab97b48dcb04404ad40b5f44e132164 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
97 schema:name Atrioventricular Block
98 rdf:type schema:DefinedTerm
99 N5bc2a5df4ab94a7f8cdaf7a9e0b29c47 rdf:first sg:person.01364536725.09
100 rdf:rest Na8e6671991f54872a7dba9268d8cef61
101 N64825870e1d14609a8cb65bb88612a2e schema:name dimensions_id
102 schema:value pub.1009392785
103 rdf:type schema:PropertyValue
104 N64a0e09d5b2048d78f8b908c1080bcf4 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
105 schema:name Aged
106 rdf:type schema:DefinedTerm
107 N6885a26ac3e74e84aa8ca70242107ac5 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
108 schema:name Clarithromycin
109 rdf:type schema:DefinedTerm
110 N74fda738023b4ad6b98df66d1ef21ba0 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
111 schema:name Drug Interactions
112 rdf:type schema:DefinedTerm
113 N793c0381988a49b7a7bdfa4fd4253c6c schema:volumeNumber 29
114 rdf:type schema:PublicationVolume
115 N84b09424fe954d7ea6a615e64c60e8f2 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
116 schema:name Cardiovascular Diseases
117 rdf:type schema:DefinedTerm
118 N8b7c926f0c424094a234eb7b930bdedd schema:name Sunnybrook Health Sciences Centre, Institute for Clinical Evaluative Sciences, Toronto, ON, Canada
119 rdf:type schema:Organization
120 N8bb632a180994ad1af86bd4a6814925e schema:name readcube_id
121 schema:value 2cbe6e73eecccaaad6868c3c9cde97f0b22fa28068700b7dc2b67328a4aa8fc8
122 rdf:type schema:PropertyValue
123 N95d30dfc24a549e28434852d1e0ebf98 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
124 schema:name Cohort Studies
125 rdf:type schema:DefinedTerm
126 N996014262d5d43a9b80af89350a0a140 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
127 schema:name Macrolides
128 rdf:type schema:DefinedTerm
129 Na8e6671991f54872a7dba9268d8cef61 rdf:first sg:person.01261146362.20
130 rdf:rest N1a256317034e4a6a89bb3b6d77c02f11
131 Na954049789894d9c97331e04832f8cff schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
132 schema:name Indans
133 rdf:type schema:DefinedTerm
134 Nacf52cb65ab64ca3a0e2ecb2ae821c78 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
135 schema:name Anti-Bacterial Agents
136 rdf:type schema:DefinedTerm
137 Nae547a0332a84e56ab8e443c195f9e02 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
138 schema:name Cytochrome P-450 CYP3A Inhibitors
139 rdf:type schema:DefinedTerm
140 Naeb1c1f17fa04e668ff96d4274488e67 schema:name doi
141 schema:value 10.2165/11599090-000000000-00000
142 rdf:type schema:PropertyValue
143 Naf3168c321db4540b138ff662c1ac2c1 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
144 schema:name Humans
145 rdf:type schema:DefinedTerm
146 Nb2212656afc54aa6b6416e399d6db0d0 rdf:first sg:person.01144717762.18
147 rdf:rest Nca05bc1350c2484f9ead14355acc818f
148 Nb77b23be55e6432f818f03ec6982d502 rdf:first sg:person.01234641247.26
149 rdf:rest N5bc2a5df4ab94a7f8cdaf7a9e0b29c47
150 Nc0237d71d28f49c3b5ed09ed12172b50 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
151 schema:name Case-Control Studies
152 rdf:type schema:DefinedTerm
153 Nc7f32303cbc640e9a366c72dd1da1d3d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
154 schema:name Piperidines
155 rdf:type schema:DefinedTerm
156 Nca05bc1350c2484f9ead14355acc818f rdf:first sg:person.01056752152.84
157 rdf:rest Nb77b23be55e6432f818f03ec6982d502
158 Ncbf778a7d73d47b5b49f539b37277ad6 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
159 schema:name Male
160 rdf:type schema:DefinedTerm
161 Nd8fa63087089405d9bb3593270f5d543 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
162 schema:name Aged, 80 and over
163 rdf:type schema:DefinedTerm
164 Ndd98dbf384db4b6c99da10c2f3e415c0 schema:name nlm_unique_id
165 schema:value 9102074
166 rdf:type schema:PropertyValue
167 Ne619040c0ff34d3582c2a5513086f518 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
168 schema:name Bradycardia
169 rdf:type schema:DefinedTerm
170 Nea6bcb5dca34425787782b18dd29a0ec schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
171 schema:name Female
172 rdf:type schema:DefinedTerm
173 Nf4928080726947e78e45fbe15c9b2f2c schema:name Sunnybrook Health Sciences Centre, Institute for Clinical Evaluative Sciences, Toronto, ON, Canada
174 rdf:type schema:Organization
175 Nfa13abceb07e435f973b8c927cb09aa7 schema:name pubmed_id
176 schema:value 22372724
177 rdf:type schema:PropertyValue
178 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
179 schema:name Medical and Health Sciences
180 rdf:type schema:DefinedTerm
181 anzsrc-for:1117 schema:inDefinedTermSet anzsrc-for:
182 schema:name Public Health and Health Services
183 rdf:type schema:DefinedTerm
184 sg:journal.1100990 schema:issn 1170-229X
185 1179-1969
186 schema:name Drugs & Aging
187 rdf:type schema:Periodical
188 sg:person.01005772611.81 schema:affiliation https://www.grid.ac/institutes/grid.17063.33
189 schema:familyName Rochon
190 schema:givenName Paula A.
191 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01005772611.81
192 rdf:type schema:Person
193 sg:person.01056752152.84 schema:affiliation Nf4928080726947e78e45fbe15c9b2f2c
194 schema:familyName Wang
195 schema:givenName Xuesong
196 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01056752152.84
197 rdf:type schema:Person
198 sg:person.01144717762.18 schema:affiliation N40eaa66743124fe88e4d6b167b17a415
199 schema:familyName Fischer
200 schema:givenName Hadas D.
201 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01144717762.18
202 rdf:type schema:Person
203 sg:person.01234641247.26 schema:affiliation https://www.grid.ac/institutes/grid.17063.33
204 schema:familyName Gruneir
205 schema:givenName Andrea
206 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01234641247.26
207 rdf:type schema:Person
208 sg:person.01261146362.20 schema:affiliation https://www.grid.ac/institutes/grid.410356.5
209 schema:familyName Gill
210 schema:givenName Sudeep S.
211 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01261146362.20
212 rdf:type schema:Person
213 sg:person.013547764572.30 schema:affiliation https://www.grid.ac/institutes/grid.17063.33
214 schema:familyName Anderson
215 schema:givenName Geoffrey M.
216 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.013547764572.30
217 rdf:type schema:Person
218 sg:person.01364536725.09 schema:affiliation N8b7c926f0c424094a234eb7b930bdedd
219 schema:familyName Daneman
220 schema:givenName Nick
221 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01364536725.09
222 rdf:type schema:Person
223 sg:person.0653763073.75 schema:affiliation https://www.grid.ac/institutes/grid.17063.33
224 schema:familyName Hutson
225 schema:givenName Janine R.
226 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0653763073.75
227 rdf:type schema:Person
228 sg:pub.10.1007/s00228-005-0946-1 schema:sameAs https://app.dimensions.ai/details/publication/pub.1038725195
229 https://doi.org/10.1007/s00228-005-0946-1
230 rdf:type schema:CreativeWork
231 sg:pub.10.1007/s00228-006-0168-1 schema:sameAs https://app.dimensions.ai/details/publication/pub.1030133192
232 https://doi.org/10.1007/s00228-006-0168-1
233 rdf:type schema:CreativeWork
234 sg:pub.10.1038/clpt.2009.127 schema:sameAs https://app.dimensions.ai/details/publication/pub.1049257231
235 https://doi.org/10.1038/clpt.2009.127
236 rdf:type schema:CreativeWork
237 sg:pub.10.1046/j.1525-1497.2001.016006376.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1034909896
238 https://doi.org/10.1046/j.1525-1497.2001.016006376.x
239 rdf:type schema:CreativeWork
240 https://doi.org/10.1001/archinternmed.2009.43 schema:sameAs https://app.dimensions.ai/details/publication/pub.1039314358
241 rdf:type schema:CreativeWork
242 https://doi.org/10.1001/archinternmed.2010.37 schema:sameAs https://app.dimensions.ai/details/publication/pub.1008758374
243 rdf:type schema:CreativeWork
244 https://doi.org/10.1002/pds.1746 schema:sameAs https://app.dimensions.ai/details/publication/pub.1018332592
245 rdf:type schema:CreativeWork
246 https://doi.org/10.1016/j.jjcc.2009.03.011 schema:sameAs https://app.dimensions.ai/details/publication/pub.1009008299
247 rdf:type schema:CreativeWork
248 https://doi.org/10.1046/j.1365-2125.1998.0460s1025.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1056732607
249 rdf:type schema:CreativeWork
250 https://doi.org/10.1046/j.1365-2125.1998.0460s1030.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1056732608
251 rdf:type schema:CreativeWork
252 https://doi.org/10.1056/nejmoa055191 schema:sameAs https://app.dimensions.ai/details/publication/pub.1027423537
253 rdf:type schema:CreativeWork
254 https://doi.org/10.1086/313959 schema:sameAs https://app.dimensions.ai/details/publication/pub.1015775451
255 rdf:type schema:CreativeWork
256 https://doi.org/10.1093/ageing/afq158 schema:sameAs https://app.dimensions.ai/details/publication/pub.1024045720
257 rdf:type schema:CreativeWork
258 https://doi.org/10.1111/j.1532-5415.2009.02488.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1032550522
259 rdf:type schema:CreativeWork
260 https://doi.org/10.1159/000068781 schema:sameAs https://app.dimensions.ai/details/publication/pub.1002677138
261 rdf:type schema:CreativeWork
262 https://doi.org/10.1345/aph.1l432 schema:sameAs https://app.dimensions.ai/details/publication/pub.1033480476
263 rdf:type schema:CreativeWork
264 https://doi.org/10.1371/journal.pmed.1000157 schema:sameAs https://app.dimensions.ai/details/publication/pub.1042241562
265 rdf:type schema:CreativeWork
266 https://doi.org/10.1503/cmaj.100702 schema:sameAs https://app.dimensions.ai/details/publication/pub.1037966301
267 rdf:type schema:CreativeWork
268 https://www.grid.ac/institutes/grid.17063.33 schema:alternateName University of Toronto
269 schema:name Faculty of Medicine, University of Toronto, Toronto, ON, Canada
270 Institute of Health Policy, Management, and Evaluation, University of Toronto, Toronto, ON, Canada
271 Sunnybrook Health Sciences Centre, Institute for Clinical Evaluative Sciences, Toronto, ON, Canada
272 Women’s College Research Institute, Women’s College Hospital, Toronto, ON, Canada
273 rdf:type schema:Organization
274 https://www.grid.ac/institutes/grid.410356.5 schema:alternateName Queen's University
275 schema:name Department of Medicine, Queen’s University, Kingston, ON, Canada
276 Sunnybrook Health Sciences Centre, Institute for Clinical Evaluative Sciences, Toronto, ON, Canada
277 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...